References
- Akubue, P.I., Stohs, S.J. (1992). Endrin-induced production of nitric oxide by rat peritoneal macrophages. Toxicol Lett., 62(2-3), 311-316.10.1016/0378-4274(92)90035-I
- Bastianetto, S., Zheng, W.H., Quirion, R. (2000). Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Brit. J. Pharmacol., 131(4), 711-720.10.1038/sj.bjp.0703626
- Baumane, L., Dzintare, M., Zvejniece, L., Meirena, D., Lauberte, L., Sile, V., Kalvinsh, I., Sjakste, N. (2002). Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy. Acta Anaesthesiol Scand., 46, 378-383.10.1034/j.1399-6576.2002.460408.x
- Bayard, V., Chamorro, F., Motta, J., Hollenberg, N.K. (2007). Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int. J. Med. Sci., 4(1), 53-58.10.7150/ijms.4.53
- Birrell, M.A., McCluskie, K., Wong, S., Donnelly, L.E., Barnes, P.J., Belvisi, M.G. (2005). Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J., 19(7), 840-841.10.1096/fj.04-2691fje
- Chen, C.K., Pace-Asciak, C.R. (1996). Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol., 27(2), 363-366.10.1016/0306-3623(95)02001-2
- Cíz, M., Pavelkovį, M., Gallovį, L., Krįlovį, J., Kubala, L., Lojek, A. (2008). The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7. Physiol. Res., 57(3), 393-402.10.33549/physiolres.931088
- Ferguson, L.R. (2001). Role of plant polyphenols in genomic stability. Mutat Res., 475(1-2), 89-111.10.1016/S0027-5107(01)00073-2
- Girish, C., Pradhan, S.C. (2008). Drug development for liver diseases: Focus on picroliv, ellagic acid and curcumin. Fundam. Clin. Pharmacol., 22(6), 623-632.10.1111/j.1472-8206.2008.00618.x19049667
- Hsieh, T.C., Juan, G., Darzynkiewicz, Z., Wu, J.M. (1999). Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res., 59(11), 2596-2601.
- Kleschyov, A.L., Wenzel, P., Munzel, T. (2007). Electron paramagnetic resonance (EPR) spin trapping of biological nitric oxide. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 851(1-2), 12-20.10.1016/j.jchromb.2006.10.00617070113
- Koncz, S., Horváth, E.J. (1996). Ipriflavone metabolite-III inhibits LPS-induced nitric oxide release from RAW-264.7 cells. Acta Physiol. Hung., 84(3), 223-228.
- Liu, Z., Song, Y., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., Li, N., Han, C., Liu, C. (2005). Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin. Exp. Pharmacol. Physiol., 32(12), 1049-1054.
- Manna, S.K., Mukhopadhyay, A., Aggarwal, B.B. (2000). Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 164(12), 6509-6519.10.4049/jimmunol.164.12.6509
- Olszanecki, R., Gebska, A., Kozlovski, V.I., Gryglewski, R.J. (2002). Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol., 53(4 Pt. 1), 571-584.
- Orallo, F., Alvarez, E., Camiña, M., Leiro, J.M., Gómez, E., Fernández, P. (2002). The possible implication of trans-Resveratrol in the cardio-protective effects of long-term moderate wine consumption. Mol. Pharmacol., 61(2), 294-302.10.1124/mol.61.2.294
- Salerno, J.C., Ghosh, D.K. (2009). Space, time and nitric oxide — neuronal nitric oxide synthase generates signal pulses. FEBS J., 276(22), 6677-6688.10.1111/j.1742-4658.2009.07382.x
- Sarkar, F.H., Li, Y. (2004). Cell signaling pathways altered by natural chemopreventive agents. Mutat. Res., 555(1-2), 53-64.10.1016/j.mrfmmm.2004.04.015
- Seaver, B., Smith, J.R. (2004). Inhibition of COX isoforms by nutraceuticals. J. Herb. Pharmacother., 4(2), 11-18.10.1080/J157v04n02_02
- Sies, H., Schewe, T., Heiss, C., Kelm, M. (2005). Cocoa polyphenols and inflammatory mediators. Amer. J. Clin. Nutr., 81(1 Suppl), 304S-312S.10.1093/ajcn/81.1.304S
- Singh, R., Singh, B., Singh, S., Kumar, N., Kumar, S., Arora, S. (2008). Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del. Toxicol in Vitro., 22(8), 1965-1970.10.1016/j.tiv.2008.08.007
- Sjakste, N., Andrianov, V.G., Boucher, J.L., Shestakova, I., Baumane, L., Dzintare, M., Meirena, D., Kalvinsh, I. (2007). Paradoxical effects of two oximes on nitric oxide production by purified NO synthases, in cell culture and in animals. Nitric Oxide., 17 (3-4), 107-114.10.1016/j.niox.2007.06.007
- Sjakste, N., Baumane, L., Meirena, D., Lauberte, L., Dzintare, M., Kalvinsh, I. (1999). Drastic increase in nitric oxide content in rat brain under halothane anaesthesia, revealed by EPR method. Biochem Pharmacol., 58, 1955-1959.10.1016/S0006-2952(99)00281-6
- Sjakste, N., Baumane, L., Meirena, D., Lauberte, L., Dzintare, M., Kalvinsh, I. (1999). Nitric oxide and anaesthetic action mechanisms, with focus on halothane. Proc. Latv. Acad. Sci., Sect B, 53(6), 301-307.
- Sjakste, N., Kleschyov, A.L., Boucher, J.L., Baumane, L., Dzintare, M., Meirena, D., Sjakste, J., Sydow, K., Münzel, T., Kalvinsh, I. (2004). Endothelium- and nitric oxide-dependent vasorelaxing activities of gammabutyrobetaine esters: Possible link to the antiischemic activities of mildronate. Eur. J. Pharmacol., 495, 67-73.10.1016/j.ejphar.2004.05.00615219822
- Sjakste, N., Sjakste, J., Boucher, J.L., Baumane, L., Sjakste, T., Dzintare, M., Meirena, D., Sharipova, J., Kalvinsh, I. (2005). Putative role of nitric oxide synthase isoforms in the changes of nitric oxide concentration in rat brain cortex and cerebellum following sevoflurane and isoflurane anaesthesia. Eur. J. Pharmacol., 513, 193-205.10.1016/j.ejphar.2005.03.014
- Soliman, K.F., Mazzio, E.A. (1998). In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med., 218(4), 390-397.10.3181/00379727-218-44309
- Wadsworth, T.L., Koop, D.R. (1999) Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol., 57(8), 941-949.10.1016/S0006-2952(99)00002-7
- Wallerath, T., Li., H., Godtel-Ambrust, U., Schwarz, P.M., Forstermann, U. (2005). Ablend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide., 12(2), 97-10410.1016/j.niox.2004.12.00415740983
- Сьяксте Н.И., Дзинтаре М.Я., Баумане Л.Х., Мейрена Д.В., Ляуберте Л.Я., Калвинып И.Я. (2001). Роль оксида азота (NO) в механизме действия средств для наркоза [Role of nitric oxide (NO) in the mechanism of anesthetic action]. Анестезиология и реаниматология. 3, 61-65 (in Russian).